ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
CD4 Therapeutics GmbH
The Office of Councilmember Nithya Raman is seeking a digital communications professional to manage and create digital content, engage constituents, and support policy communication through social media, email, and website management. The role involves developing strategies, producing multimedia content, analyzing performance metrics, and collaborating with a creative team.
CD4 Therapeutics GmbH is a Munich-based biopharmaceutical company founded in 2024 that is developing first-in-class immunotherapies for autoimmune and inflammatory diseases. Its lead asset, Tregalizumab, is the only monoclonal antibody designed to selectively activate regulatory T-cells (Tregs), with initial indications targeting Oral Lichen Planus and Acute Graft-versus-Host Disease. The company holds a worldwide exclusive licence for Tregalizumab and is pursuing a biomarker-driven development strategy with potential expansion into larger autoimmune markets including rheumatoid arthritis, atopic dermatitis, and inflammatory bowel disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CD4 Therapeutics GmbH.
CD4 Therapeutics GmbH didn’t post a salary, so this is our estimate from similar listings.